The Prayas ePathshala

Exams आसान है !

10 January 2023 – The Hindu

Facebook
LinkedIn
WhatsApp

Taming Defiant Bugs

Context:

  • Antibiotic resistance, also known as antimicrobial resistance, is a problem that will soon have a global impact on public health (AMR).
  • It is one of the top 10 health hazards to humanity, according to the WHO.
  • The foundation of modern medicine is antimicrobials, which are substances or agents that eliminate hazardous germs. Misused antibiotics subject organisms to natural selection pressure.
  • While the most drug-resistant bacteria swiftly perish, the most resilient ones live, reproduce, and develop into superbugs.
  • As a result, AMR happens when superbugs emerge and antibiotics begin to lose their effectiveness.
  • These microorganisms have the ability to infect both humans and animals, and their illnesses are more difficult to treat than those brought on by non-resistant bacteria.
  • The abuse of antibiotics in humans and animals hastens the occurrence of antibiotic resistance, a natural phenomena.
  • By the year 2050, AMR is predicted to result in 10 million annual fatalities if coordinated action is not done today. The production of cattle will be reduced by 7.5%, and the global GDP would be severely affected by 3.5%.

About AMR, or antimicrobial resistance:

  • Antibiotic resistance (AMR) is a condition where bacteria, viruses, fungi, and parasites alter over time and cease responding to antibiotics, making infections more difficult to cure and raising the risk of disease transmission, serious illness, and death.
  • Drug resistance makes antibiotics and other antimicrobial therapies useless and makes treating illnesses more challenging or impossible.

What causes AMR specifically?

  • The formation of bacteria that are resistant to treatment unintentionally results from the antibiotics that doctors mistakenly give.
  • Widespread Agricultural Use: Antibiotics are routinely used to boost livestock growth in both industrialised and developing nations.
  • New Antibiotics Are Now Available in Several Forms:
  • Due to financial and legal barriers, the pharmaceutical industry’s efforts to create new antibiotics—a technique that has previously been effective in battling resistant microbes—have basically stalled. The pharmaceutical industry no longer views antibiotic research as a wise financial venture.
  • Getting regulatory approval is frequently challenging, even for companies that are fervently searching for novel medications.

Creating a treatment for AMR:

  • The Covid-19 outbreak has starkly served as a reminder of what it’s like to battle a dangerous sickness without a vaccine or treatment. Covid has also shown that society, business, and the government can cooperate to create crisis-related solutions.
  • Because we are products of Darwinian evolution, it is challenging to reverse AMR and/or develop remedies for it. As we observed during the Covid outbreak, coordination between the national and international community is therefore required.
  • To deal with AMR and find solutions, one must negotiate the different spheres of science and society. AMR national action plans (NAPs) have been implemented for the benefit of human health in some of the economies under consideration, including India.

Initiatives on a national and international level to combat AMR?

  • India is now officially recognised as a member of the Global Antimicrobial Resistance (AMR) Research and Development (R&D) Hub.
  • (In connection with the 71st World Health Assembly, the Global AMR R&D Hub was established in May 2018 in response to a request from G20 Leaders in 2017).

The Health Ministry’s implementation of the Red Line initiative:

  • It uses drugs without a prescription, including antibiotics, that have a red vertical line by their names.
  • The term “Medicines with the Red Line” is used to describe these drugs.
  • The “red line,” which prevents inappropriate intake, will help consumers distinguish antibiotics from other medicines.
  • Antibiotic resistance and other types of antimicrobial resistance are addressed in the World Health Organization’s Global Action Plan on AMR (2015).
  • The primary causes of AMR are the overuse and misuse of antibiotics in humans, animals, and agriculture.
  • Therefore, coordinated efforts across all industries are needed to ensure the proper use of antibiotics in people, animals, and crops.

To try to reverse AMR, the additional steps listed below can be implemented locally, either jointly or individually:

  • Preventing infections whenever possible is equal to avoiding resistance since disease prevention and wellness are essential to public health.
  • Monitoring cleaning measures, ensuring access to clean water, and supporting hospital-led infection-control programmes are essential.
  • Antimicrobials must only be prescribed in the most dire situations in order to reduce AMR.
  • Stopping the overuse of antibiotics in farming, which results in the development of drug-resistant bacteria in our food supply, requires cooperation between the animal and environmental sectors.
  • a protracted vaccination campaign Vaccines will help you avoid getting sick and may even be able to stop the spread of AMR diseases.
  • For many infectious diseases, immunisation programmes are still far from comprehensive and finished.
  • By enabling us to identify resistant illnesses of every kind in the environment and hospitals, a good surveillance system will eventually enable containment, which is strongly tied to prevention.

Spending more on research and development with support from both public and commercial sources:

  • A robust pipeline of novel antibiotics is urgently required since it is crucial to reestablishing equilibrium and providing us with new weapons in the fight against AMR.
  • The creation of a new antibiotic takes more than ten years and costs upwards of $1 billion, from basic research to clinical trials.
  • These medications don’t generate a lot of revenue, though. In light of this, the fourth recommendation would be to develop creative financial incentives that would sever the traditional link between sales and profits and gauge profitability using the antibiotic’s social worth instead.
  • Since antibiotics and other antimicrobial therapies are finite resources that should be made available to everyone, we must adopt a shared moral perspective on AMR.

Conclusion:

  • For individuals who are exposed to it, the existence of AMR poses a major risk. For individuals who encounter them, chronic sickness, mortality, and incapacity-related lengthy hospital stays are enormously expensive.
  • Modern medicine, women’s health, infectious diseases, surgery, and cancer risks would all rise without effective antimicrobials.
  • Because AMR has a high monetary cost, developing and implementing policies must follow a thorough “One Health” approach.

Select Course